Modulation of advanced glycation endproducts (AGEs) signaling in experimentally induced stroke in mice.
Authors:
Open Access
- 11 October 2020
- journal article
- research article
- Published by Egyptian Knowledge Bank in Zagazig Journal of Pharmaceutical Sciences
Abstract
Stroke is a leading cause of death and permanent disability in adults worldwide. Advanced glycation endproducts (AGEs) are known to be increased in several chronic diseases and induce inflammation and protein crosslinking. The current study was designed to investigate the protective effect of benfotiamine, perindopril (at a sub-hypotensive dose), and alagebrium on experimentally induced stroke in mice. All drugs were administered for 9 days starting one week before middle cerebral artery occlusion (MCAO). Benfotiamine, perindopril and alagebrium ameliorated the deleterious effects of MCAO as indicated by the improvement in the performance of the animals in behavior tests and the reduction in brain infarction. This was associated with normalization of the levels of receptor for advanced glycation end products (RAGE) and its soluble form sRAGE that were changed following MCAO. In addition, benfotiamine, perindopril and alagebrium corrected the upregulation in the downstream effectors TNF-α and VCAM-1. The results of the current study represent a new indication for benfotiamine, perindopril, alagebrium in the management of ischemic stroke.Keywords
This publication has 44 references indexed in Scilit:
- Elevated Plasma Level of Soluble Form of RAGE in Ischemic Stroke Patients with DementiaNeuroMolecular Medicine, 2017
- Modulation of cerebral RAGE expression following nitric oxide synthase inhibition in rats subjected to focal cerebral ischemiaEuropean Journal of Pharmacology, 2017
- RETRACTED: Candesartan and glycyrrhizin ameliorate ischemic brain damage through downregulation of the TLR signaling cascadeEuropean Journal of Pharmacology, 2014
- Role of Inflammation and Its Mediators in Acute Ischemic StrokeJournal of Cardiovascular Translational Research, 2013
- Inhibition of AGEs formation by natural productsAmino Acids, 2013
- Toll-like receptors in inflammation of the central nervous systemInternational Immunopharmacology, 2011
- Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's diseaseBrain Research, 2010
- Effects of gemfibrozil on outcome after permanent middle cerebral artery occlusion in miceBrain Research, 2009
- NF-κB induces PGE2-synthesizing enzymes in neuronsNaunyn-Schmiedeberg's Archives of Pharmacology, 2009
- The relationship of glycaemic level to advanced glycation end-product (AGE) accumulation and retinal pathology in the spontaneous diabetic hamsterDiabetologia, 1998